135 related articles for article (PubMed ID: 9498102)
1. Quantification of the N-terminal propeptide of human procollagen type I (PINP): comparison of ELISA and RIA with respect to different molecular forms.
Jensen CH; Hansen M; Brandt J; Rasmussen HB; Jensen PB; Teisner B
Clin Chim Acta; 1998 Jan; 269(1):31-41. PubMed ID: 9498102
[TBL] [Abstract][Full Text] [Related]
2. Procollagen type I N-terminal propeptide (PINP) as an indicator of type I collagen metabolism: ELISA development, reference interval, and hypovitaminosis D induced hyperparathyroidism.
Orum O; Hansen M; Jensen CH; Sørensen HA; Jensen LB; Hørslev-Petersen K; Teisner B
Bone; 1996 Aug; 19(2):157-63. PubMed ID: 8853860
[TBL] [Abstract][Full Text] [Related]
3. Thermal instability of the trimeric structure of the N-terminal propeptide of human procollagen type I in relation to assay technology.
Brandt J; Krogh TN; Jensen CH; Frederiksen JK; Teisner B
Clin Chem; 1999 Jan; 45(1):47-53. PubMed ID: 9895337
[TBL] [Abstract][Full Text] [Related]
4. The aminoterminal propeptide of type I procollagen: evaluation of a commercial radioimmunoassay kit and values in healthy subjects.
Tähtelä R; Turpeinen M; Sorva R; Karonen SL
Clin Biochem; 1997 Feb; 30(1):35-40. PubMed ID: 9056107
[TBL] [Abstract][Full Text] [Related]
5. Difference between total and intact assays for N-terminal propeptide of type I procollagen reflects degradation of pN-collagen rather than denaturation of intact propeptide.
Koivula MK; Ruotsalainen V; Björkman M; Nurmenniemi S; Ikäheimo R; Savolainen K; Sorva A; Risteli J
Ann Clin Biochem; 2010 Jan; 47(Pt 1):67-71. PubMed ID: 19940208
[TBL] [Abstract][Full Text] [Related]
6. Comparison of total and intact aminoterminal propeptide of type I procollagen assays in patients with breast cancer with or without bone metastases.
Marin L; Koivula MK; Jukkola-Vuorinen A; Leino A; Risteli J
Ann Clin Biochem; 2011 Sep; 48(Pt 5):447-51. PubMed ID: 21733929
[TBL] [Abstract][Full Text] [Related]
7. Type I and type III procollagen propeptides in amniotic fluid of normal pregnancies and in a case of mild osteogenesis imperfecta.
Kauppila S; Tekay A; Risteli L; Koivisto M; Risteli J
Eur J Clin Invest; 1998 Oct; 28(10):831-7. PubMed ID: 9792997
[TBL] [Abstract][Full Text] [Related]
8. Enzyme-linked immunosorbent serum assays (ELISAs) for rat and human N-terminal pro-peptide of collagen type I (PINP)--assessment of corresponding epitopes.
Leeming DJ; Larsen DV; Zhang C; Hi Y; Veidal SS; Nielsen RH; Henriksen K; Zheng Q; Barkholt V; Riis BJ; Byrjalsen I; Qvist P; Karsdal MA
Clin Biochem; 2010 Oct; 43(15):1249-56. PubMed ID: 20709044
[TBL] [Abstract][Full Text] [Related]
9. Immunoassay for intact amino-terminal propeptide of human type I procollagen.
Melkko J; Kauppila S; Niemi S; Risteli L; Haukipuro K; Jukkola A; Risteli J
Clin Chem; 1996 Jun; 42(6 Pt 1):947-54. PubMed ID: 8665688
[TBL] [Abstract][Full Text] [Related]
10. Synthetic peptide-based immunoassay for amino-terminal propeptide of type I procollagen: application for evaluation of bone formation.
Linkhart SG; Linkhart TA; Taylor AK; Wergedal JE; Bettica P; Baylink DJ
Clin Chem; 1993 Nov; 39(11 Pt 1):2254-8. PubMed ID: 8222218
[TBL] [Abstract][Full Text] [Related]
11. Purification and characterization of the N-terminal propeptide of human type III procollagen.
Niemelä O; Risteli L; Parkkinen J; Risteli J
Biochem J; 1985 Nov; 232(1):145-50. PubMed ID: 4084223
[TBL] [Abstract][Full Text] [Related]
12. Assessing bone formation in patients with chronic kidney disease using procollagen type I N-terminal propeptide (PINP): The choice of assay makes a difference.
Tridimas A; Milan A; Marks E
Ann Clin Biochem; 2021 Sep; 58(5):528-536. PubMed ID: 34096326
[TBL] [Abstract][Full Text] [Related]
13. Measurement of aminoterminal propeptide of type I procollagen (PINP) in serum.
Koivula MK; Risteli L; Risteli J
Clin Biochem; 2012 Aug; 45(12):920-7. PubMed ID: 22480789
[TBL] [Abstract][Full Text] [Related]
14. Hepatic and renal extraction of circulating type I procollagen aminopropeptide in patients with normal liver function and in patients with alcoholic cirrhosis.
Schytte S; Hansen M; Møller S; Junker P; Henriksen JH; Hillingsø J; Teisner B
Scand J Clin Lab Invest; 1999 Dec; 59(8):627-33. PubMed ID: 10691054
[TBL] [Abstract][Full Text] [Related]
15. A radioimmunoassay for the N-terminal propeptide of rat procollagen type III. Application to the study of the uptake of the N-terminal propeptide of procollagen type III in isolated perfused rat liver.
Brocks DG; Steinert C; Gerl M; Knolle J; Neubauer HP; Günzler V
Matrix; 1993 Sep; 13(5):381-7. PubMed ID: 7504165
[TBL] [Abstract][Full Text] [Related]
16. The typing of fetal antigen 2 in human amniotic fluid.
Price KM; Silman R; Armstrong P; Teisner B; Grudzinskas JG
Clin Chim Acta; 1995 May; 236(2):181-94. PubMed ID: 7554285
[TBL] [Abstract][Full Text] [Related]
17. Radioimmunoassay of the carboxyterminal propeptide of human type I procollagen.
Melkko J; Niemi S; Risteli L; Risteli J
Clin Chem; 1990 Jul; 36(7):1328-32. PubMed ID: 2372946
[TBL] [Abstract][Full Text] [Related]
18. Aminoterminal propeptide of type III procollagen in cord blood and amniotic fluid of appropriate-for-gestational-age infants: a predictor of age-related fetal growth rate.
Vanhaesebrouck P; Kint J; Dhont M; De Praeter C; Leroy J
Pediatr Res; 1994 Jul; 36(1 Pt 1):64-70. PubMed ID: 7936839
[TBL] [Abstract][Full Text] [Related]
19. Procollagen types I and III aminoterminal propeptide levels during acute respiratory distress syndrome and in response to methylprednisolone treatment.
Meduri GU; Tolley EA; Chinn A; Stentz F; Postlethwaite A
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1432-41. PubMed ID: 9817690
[TBL] [Abstract][Full Text] [Related]
20. Purification of human procollagen type I carboxyl-terminal propeptide cleaved as in vivo from procollagen and used to calibrate a radioimmunoassay of the propeptide.
Pedersen BJ; Bonde M
Clin Chem; 1994 May; 40(5):811-6. PubMed ID: 8174256
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
